Selected research
Industry Growth & Trends
Global AI Drug Repurposing Platform Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Drug Repurposing Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Drug Repurposing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Drug Repurposing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Drug Repurposing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Drug Repurposing Platform market include Recursion, Lantern Pharma, SOM Biotech, Standigm, Pharos iBio, Aitia, Causaly, BenevolentAI and Healx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Drug Repurposing Platform market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Drug Repurposing Platform market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Drug Repurposing Platform market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Drug Repurposing Platform.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Drug Repurposing Platform market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Drug Repurposing Platform Market by Company
Recursion
Lantern Pharma
SOM Biotech
Standigm
Pharos iBio
Aitia
Causaly
BenevolentAI
Healx
Insilico Medicine
AI Drug Repurposing Platform Segment by Type
Target and Mechanism Mining
Drug–Disease Matching
Indication Expansion
Combination Therapy Prediction
Evidence Ranking and Validation
Safety and Translational Assessment
AI Drug Repurposing Platform Segment by Application
Rare Disease Repurposing
Oncology Indication Expansion
Infectious Disease Response
CNS and Neurology Research
Immunology and Inflammation Research
Asset Rescue and Pipeline Optimization
AI Drug Repurposing Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Repurposing Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Repurposing Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Repurposing Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Drug Repurposing Platform companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Target and Mechanism Mining
- Drug–Disease Matching
- Indication Expansion
- Combination Therapy Prediction
- Evidence Ranking and Validation
- Safety and Translational Assessment
Applications
- Rare Disease Repurposing
- Oncology Indication Expansion
- Infectious Disease Response
- CNS and Neurology Research
- Immunology and Inflammation Research
- Asset Rescue and Pipeline Optimization
Companies covered
- Recursion
- Lantern Pharma
- SOM Biotech
- Standigm
- Pharos iBio
- Aitia
- Causaly
- BenevolentAI
- Healx
- Insilico Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Drug Repurposing Platform Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Drug Repurposing Platform Market Size by Region (2021-2032)
- 1.4.1 Global AI Drug Repurposing Platform Market Size by Region (2021-2026)
- 1.4.2 Global AI Drug Repurposing Platform Market Size by Region (2027-2032)
- 1.5 Key Regions AI Drug Repurposing Platform Market Size (2021-2032)
- 1.5.1 North America AI Drug Repurposing Platform Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Drug Repurposing Platform Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Drug Repurposing Platform Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Drug Repurposing Platform Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Drug Repurposing Platform Market Size Growth Rate (2021-2032)
2 AI Drug Repurposing Platform Market by Type
- 2.1 Type Introduction
- 2.1.1 Target and Mechanism Mining
- 2.1.2 Drug–Disease Matching
- 2.1.3 Indication Expansion
- 2.1.4 Combination Therapy Prediction
- 2.1.5 Evidence Ranking and Validation
- 2.1.6 Safety and Translational Assessment
- 2.2 Global AI Drug Repurposing Platform Market Size by Type
- 2.2.1 Global AI Drug Repurposing Platform Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Drug Repurposing Platform Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Drug Repurposing Platform Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Drug Repurposing Platform Market Size by Regions
- 2.3.1 North America AI Drug Repurposing Platform Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Drug Repurposing Platform Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Drug Repurposing Platform Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Drug Repurposing Platform Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Drug Repurposing Platform Market Size Breakdown by Type (2021-2026)
3 AI Drug Repurposing Platform Market by Application
- 3.1 Type Introduction
- 3.1.1 Rare Disease Repurposing
- 3.1.2 Oncology Indication Expansion
- 3.1.3 Infectious Disease Response
- 3.1.4 CNS and Neurology Research
- 3.1.5 Immunology and Inflammation Research
- 3.1.6 Asset Rescue and Pipeline Optimization
- 3.2 Global AI Drug Repurposing Platform Market Size by Application
- 3.2.1 Global AI Drug Repurposing Platform Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Drug Repurposing Platform Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Drug Repurposing Platform Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Drug Repurposing Platform Market Size by Regions
- 3.3.1 North America AI Drug Repurposing Platform Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Drug Repurposing Platform Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Drug Repurposing Platform Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Drug Repurposing Platform Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Drug Repurposing Platform Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Drug Repurposing Platform Industry Trends
- 4.2 AI Drug Repurposing Platform Industry Drivers
- 4.3 AI Drug Repurposing Platform Industry Opportunities and Challenges
- 4.4 AI Drug Repurposing Platform Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Drug Repurposing Platform Revenue (2021-2026)
- 5.2 Global AI Drug Repurposing Platform Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Drug Repurposing Platform Key Company Headquarters & Area Served
- 5.4 Global AI Drug Repurposing Platform Company, Product Type & Application
- 5.5 Global AI Drug Repurposing Platform Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Drug Repurposing Platform Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Drug Repurposing Platform Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Drug Repurposing Platform Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Recursion
- 6.1.1 Recursion Company Information
- 6.1.2 Recursion Business Overview
- 6.1.3 Recursion AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Recursion AI Drug Repurposing Platform Product Portfolio
- 6.1.5 Recursion Recent Developments
- 6.2 Lantern Pharma
- 6.2.1 Lantern Pharma Company Information
- 6.2.2 Lantern Pharma Business Overview
- 6.2.3 Lantern Pharma AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Lantern Pharma AI Drug Repurposing Platform Product Portfolio
- 6.2.5 Lantern Pharma Recent Developments
- 6.3 SOM Biotech
- 6.3.1 SOM Biotech Company Information
- 6.3.2 SOM Biotech Business Overview
- 6.3.3 SOM Biotech AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 SOM Biotech AI Drug Repurposing Platform Product Portfolio
- 6.3.5 SOM Biotech Recent Developments
- 6.4 Standigm
- 6.4.1 Standigm Company Information
- 6.4.2 Standigm Business Overview
- 6.4.3 Standigm AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Standigm AI Drug Repurposing Platform Product Portfolio
- 6.4.5 Standigm Recent Developments
- 6.5 Pharos iBio
- 6.5.1 Pharos iBio Company Information
- 6.5.2 Pharos iBio Business Overview
- 6.5.3 Pharos iBio AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Pharos iBio AI Drug Repurposing Platform Product Portfolio
- 6.5.5 Pharos iBio Recent Developments
- 6.6 Aitia
- 6.6.1 Aitia Company Information
- 6.6.2 Aitia Business Overview
- 6.6.3 Aitia AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Aitia AI Drug Repurposing Platform Product Portfolio
- 6.6.5 Aitia Recent Developments
- 6.7 Causaly
- 6.7.1 Causaly Company Information
- 6.7.2 Causaly Business Overview
- 6.7.3 Causaly AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Causaly AI Drug Repurposing Platform Product Portfolio
- 6.7.5 Causaly Recent Developments
- 6.8 BenevolentAI
- 6.8.1 BenevolentAI Company Information
- 6.8.2 BenevolentAI Business Overview
- 6.8.3 BenevolentAI AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 BenevolentAI AI Drug Repurposing Platform Product Portfolio
- 6.8.5 BenevolentAI Recent Developments
- 6.9 Healx
- 6.9.1 Healx Company Information
- 6.9.2 Healx Business Overview
- 6.9.3 Healx AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Healx AI Drug Repurposing Platform Product Portfolio
- 6.9.5 Healx Recent Developments
- 6.10 Insilico Medicine
- 6.10.1 Insilico Medicine Company Information
- 6.10.2 Insilico Medicine Business Overview
- 6.10.3 Insilico Medicine AI Drug Repurposing Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Insilico Medicine AI Drug Repurposing Platform Product Portfolio
- 6.10.5 Insilico Medicine Recent Developments
7 North America
- 7.1 North America AI Drug Repurposing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Drug Repurposing Platform Market Size by Country (2021-2026)
- 7.3 North America AI Drug Repurposing Platform Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Drug Repurposing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Drug Repurposing Platform Market Size by Country (2021-2026)
- 8.3 Europe AI Drug Repurposing Platform Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Drug Repurposing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Drug Repurposing Platform Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Drug Repurposing Platform Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Drug Repurposing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Drug Repurposing Platform Market Size by Country (2021-2026)
- 10.3 South America AI Drug Repurposing Platform Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Drug Repurposing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Drug Repurposing Platform Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Drug Repurposing Platform Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst